ADAPTED and AMYPAD to hold a Featured Research Session at AAIC2020
We are pleased to report that both ADAPTED and AMYPAD projects will hold a...
RADAR-AD launches its bi-yearly newsletter
The RADAR-AD project (Remote Assessment of Disease And Relapse – Alzheimer’s Disease), which aims...
Fourth Neuronet newsletter issue launched
Welcome to the fourth issue of the Neuronet newsletter! We hope this newsletter finds...
The IMI Mobilise-D project has joined the Neuronet programme
Neuronet is a Coordination and Support Action (CSA) aiming to support and better integrate...
VUmc is recruiting a Clinical Trial Manager for the AMYPAD study
The Amsterdam UMC location VUmc is recruiting a Clinical Trial Manager for the AMYPAD...
Neurodegenerative disease research featured in the two final IMI2 Calls for proposals
The Innovative Medicines Initiative (IMI), the world’s largest public and private partnership in the...
Neuronet convenes online meetings of its four Working Groups
The Neuronet Working Groups (WGs) are cross-project spaces for experts to discuss common issues,...
Spotlight on early-career investigators: a Neuronet interview with Sarah Gregory
In this early-career researcher interview, we talk to Sarah Gregory who is a PhD...
KCL is recruiting a research assistant for the RADAR-CNS project
The Institute of Psychiatry, Psychology & Neuroscience of King’s College London is looking for...
Neuronet holds an online Scientific Coordination Board meeting
On Friday 5 June, Neuronet convened an online meeting of its Scientific Coordination Board...
EPAD V1500.0 dataset is now available to the entire research community
The European Prevention of Alzheimer’s Dementia (EPAD) project is very pleased to announce the...
RADAR-AD project publishes “Behind-the-scenes” interview series with its researchers
To show the variety of work going on “behind-the-scenes” in RADAR-AD, the project has...
Impact of the COVID-19 pandemic on the AMYPAD and EPAD projects
The worldwide COVID-19 pandemic has inevitably impacted EPAD and its sister project AMYPAD. EPAD:...
Fraunhofer SCAI launches a new COVID-19 knowledge space, building on tools developed during the AETIONOMY & PHAGO projects
On 23 April, Fraunhofer SCAI launched a new COVID-19 knowledge space which hosts tools...
New perspectives in Alzheimer’s research – Scalable culturing technique for stem cell models developed
LIFE & BRAIN GmbH, a SME based in Bonn, Germany, and partner within the...
Impact of the COVID-19 pandemic on RADAR-CNS and RADAR-AD projects
The worldwide COVID-19 pandemic has inevitably impacted several EU projects. The RADAR-CNS and RADAR-AD...
Development of the digital RADAR-BASE platform within the framework of RADAR-AD and RADAR-CNS
The IMI RADAR-AD project aims to develop a digital platform to remotely collect data from smartphone applications, wearable...
More than 1,000 clinicians complete RMT survey for the RADAR-CNS project
The Clinical Pathways team of the RADAR-CNS project has surveyed 1,009 clinicians as to...
Mercè Boada, leader of the MOPEAD project, shares her experiences of COVID-19 lockdown
During the lockdown, I am distancing myself socially whilst continuing my work for Fundació...
EPAD Coordinators comment on closure of Longitudinal Cohort Study
By now you will perhaps already be aware of the unexpected closure of the...